Table 1.
Characteristic | HIV+ (N=57) |
---|---|
Demographics | |
Age (years) | 22.6 (1.3) |
Education (years) | 12.1 (1.3) |
Estimated verbal IQ (WTAR reading) | 89.9 (13.8) |
Sex (% male) | 86.0 |
Ethnicity (%) | |
Caucasian | 12.3 |
African-American | 56.1 |
Hispanic | 29.8 |
Other | 1.8 |
Global Severity Index (% elevated)a | 33.3 |
Somatization | 31.6 |
Depression | 31.6 |
Anxiety | 33.3 |
Substance Use Disorder (%)b | |
Any | 70.2 |
Alcohol | 66.7 |
Marijuana | 56.2 |
Cocaine | 5.3 |
Methamphetamine | 17.6 |
Inhalants | 3.5 |
Sedatives | 7.0 |
Opioids | 7.0 |
Other | 1.8 |
HIV Disease | |
HIV-associated neurocognitive disorder (%) | 73.7 |
Estimated duration of infection (mos.)c | 34 (18, 52) |
Nadir CD4 T-cell count (cells/µl)c | 288 (235, 423) |
Current CD4 T-cell count (cells/µl)c | 539 (369, 671) |
Currently Immunosuppressed (% CD4 < 200) | 5.0 |
AIDS status (%) | 20.0 |
Plasma HIV RNA (% detectable) | 50.0 |
ART Use (%) | 77.2 |
Note.
Based on the Brief Symptom Inventory (BSI; Derogatis, 1993)
Based on meeting at least minimal risk criteria for substance use disorder over the past three months as measured by the Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST v. 3.0).
Data are presented as medians and interquartile ranges.
ART = Antiretroviral therapy. WTAR = Wechsler Test of Adult Reading.